Loading...
Loading...
Reuters : China approves the market launch of an invasive BCI system that helps restore hand movement, the world's first approval of such a device for commercial use — China's drug regulator said on Friday that it has given the nod for a brain-computer interface (BCI) system that helps restore hand-movement ability …
A Neuralink user says he is controlling World of Warcraft using the brain-computer interface in a demonstration that highlights progress in consumer-facing neural implants. The report centers on a patient and Neuralink, the Elon Musk-backed startup, who confirmed on social platforms that commands mapped from his neural signals were used to play the game. This matters because it showcases practical, real-time BCI control of complex software and raises questions about user experience, safety, regulatory oversight, and ethical implications as neural interfaces move from lab demos toward interactive entertainment and assistive tech. The episode underscores both the commercial potential and societal questions around implantable BCIs.
China’s National Medical Products Administration has approved Neo, a coin-sized brain implant from Neuracle Medical Technology, as the first commercially available brain chip to help people with paralysis control an assistive robotic hand. After 18 months of safety testing and trials involving about 32 participants with no reported adverse effects, the implant translates imagined movements via eight electrodes into commands for a mechanical glove that performs basic tasks. Approval arrives alongside a Chinese government plan to make the nation a global leader in brain-computer interface (BCI) tech within five years, promoting mass production of noninvasive devices and testing BCIs in high-risk industries. The move accelerates BCI commercialization and raises regulatory, ethical, and competitive stakes for global firms like Neuralink.
Max Hodak, co-founder of Neuralink, discussed the future of brain-computer interfaces on the Y Combinator podcast, outlining technical and commercial challenges for invasive and noninvasive BCI technologies. Hodak covered device miniaturization, signal fidelity, safety and regulatory hurdles, and the need for robust software and machine learning to translate neural signals into useful actions. He emphasized realistic timelines, ethical considerations, and potential medical and consumer use-cases, while noting competition and collaboration across startups and research labs. The conversation matters because Hodak’s insights signal where investment, developer tools, and productization efforts in BCI may focus next, shaping hardware, AI models, and regulatory paths in neurotech.
Reuters : China approves the market launch of an invasive BCI system that helps restore hand movement, the world's first approval of such a device for commercial use — China's drug regulator said on Friday that it has given the nod for a brain-computer interface (BCI) system that helps restore hand-movement ability …